Rafferty Asset Management, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 180 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$2,239,276
-15.5%
625,496
-12.9%
0.01%
-13.3%
Q2 2023$2,649,892
-18.4%
718,128
-26.8%
0.02%
-31.8%
Q1 2023$3,247,875
+6.0%
981,231
+24.3%
0.02%
-15.4%
Q4 2022$3,062,864
+117.4%
789,398
+36.1%
0.03%
+73.3%
Q3 2022$1,409,000579,8500.02%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 9,104,275$32,593,30510.83%
Altium Capital Management LP 2,723,011$9,748,3795.08%
Velan Capital Investment Management LP 1,736,100$6,215,2385.01%
AWM Investment Company, Inc. 5,999,872$21,479,5423.17%
Mesirow Financial Investment Management, Inc. 72,677$260,1841.13%
Caligan Partners LP 597,513$2,139,0970.98%
Perceptive Advisors 6,984,319$25,003,8620.83%
OBERWEIS ASSET MANAGEMENT INC/ 2,078,400$7,440,6720.79%
TANG CAPITAL MANAGEMENT LLC 1,360,000$4,868,8000.69%
EAM Investors, LLC 967,146$3,462,3830.67%
View complete list of ADMA BIOLOGICS INC shareholders